Abdulhadi Suwandi1, Imke Bargen, Bishnudeo Roy, Marina C Pils, Martina Krey, Susanne Zur Lage, Tina Basler, Manfred Rohde, Christine S Falk, Mathias W Hornef, Ralph Goethe, Siegfried Weiss. 1. *Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany; †Mouse Pathology, Helmholtz Centre for Infection Research, Braunschweig, Germany; ‡Institute for Microbiology, University of Veterinary Medicine Hannover, Hannover, Germany; §Central Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Germany; ‖Institute of Transplant Immunology, Integrated Research and Treatment Center, Hannover, Germany; and ¶Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Abstract
BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disorder of the human gastrointestinal tract. Although genetic, immunological, environmental, and bacterial factors have been implicated, the pathogenesis is incompletely understood. The histopathological appearance of CD strikingly resembles Johne's disease, a ruminant inflammatory bowel disease, caused by Mycobacterium avium ssp. paratuberculosis (MAP), but a causative role of MAP in CD has not been established. In this work, we hypothesized that MAP might exacerbate an already existing intestinal disease. METHODS: We combined dextran sulfate sodium (DSS)-induced colitis with MAP infection in mice and monitored the immune response and bacterial count in different organs. RESULTS: An increased size of liver and spleen was observed in DSS-treated and MAP-infected animals (DSS + MAP) as compared with DSS-treated uninfected (DSS + PBS) mice. Similarly, DSS treatment increased the number and size of MAP-induced liver granulomas and enhanced the MAP counts in enteric tissue. MAP infection in turn delayed the mucosal healing of DSS-induced tissue damage. Finally, high numbers of MAP were found in mesenteric fat tissue causing large granuloma and necrotic regions. CONCLUSIONS: Taken together, we present an in vivo model to study the role of MAP infection in CD. Our results confirm the hypothesis that MAP is able to exacerbate existing intestinal inflammation.
BACKGROUND:Crohn's disease (CD) is a chronic inflammatory disorder of the human gastrointestinal tract. Although genetic, immunological, environmental, and bacterial factors have been implicated, the pathogenesis is incompletely understood. The histopathological appearance of CD strikingly resembles Johne's disease, a ruminant inflammatory bowel disease, caused by Mycobacterium avium ssp. paratuberculosis (MAP), but a causative role of MAP in CD has not been established. In this work, we hypothesized that MAP might exacerbate an already existing intestinal disease. METHODS: We combined dextran sulfate sodium (DSS)-induced colitis with MAP infection in mice and monitored the immune response and bacterial count in different organs. RESULTS: An increased size of liver and spleen was observed in DSS-treated and MAP-infected animals (DSS + MAP) as compared with DSS-treated uninfected (DSS + PBS) mice. Similarly, DSS treatment increased the number and size of MAP-induced liver granulomas and enhanced the MAP counts in enteric tissue. MAP infection in turn delayed the mucosal healing of DSS-induced tissue damage. Finally, high numbers of MAP were found in mesenteric fat tissue causing large granuloma and necrotic regions. CONCLUSIONS: Taken together, we present an in vivo model to study the role of MAP infection in CD. Our results confirm the hypothesis that MAP is able to exacerbate existing intestinal inflammation.
Authors: Abdulhadi Suwandi; Imke Bargen; Marina C Pils; Martina Krey; Susanne Zur Lage; Anurag K Singh; Tina Basler; Christine S Falk; Ursula Seidler; Mathias W Hornef; Ralph Goethe; Siegfried Weiss Journal: Front Cell Infect Microbiol Date: 2017-03-16 Impact factor: 5.293
Authors: Thorsten Meißner; Elke Eckelt; Tina Basler; Jochen Meens; Julia Heinzmann; Abdulhadi Suwandi; Walter M R Oelemann; Sandra Trenkamp; Otto Holst; Siegfried Weiss; Boyke Bunk; Cathrin Spröer; Gerald-F Gerlach; Ralph Goethe Journal: Front Cell Infect Microbiol Date: 2014-08-14 Impact factor: 5.293